"Pioglitazone and metformin sustained release 

Pioglitazone and metformin sustained release 
PIOSTERIS M 500  are two medications commonly used in combination for the management of type 2 diabetes mellitus. Let's discuss each of these medications:
Pioglitazone: Pioglitazone belongs to the class of medications known as thiazolidinediones or glitazones. PIOSTERIS M 500   works by improving insulin sensitivity in target tissues, such as the liver, muscle, and fat cells. Pioglitazone helps reduce insulin resistance, which is a key factor in type 2 diabetes. By enhancing insulin action, it helps lower blood sugar levels.
Metformin Sustained Release: Metformin is a medication classified as a biguanide. PIOSTERIS M 500   works primarily by reducing the production of glucose in the liver and improving insulin sensitivity in peripheral tissues. Metformin helps lower blood sugar levels by reducing the amount of glucose released into the bloodstream and enhancing the uptake of glucose by the cells.
Combining  PIOSTERIS M 500  offers complementary mechanisms of action for managing type 2 diabetes:
Pioglitazone improves insulin sensitivity and reduces insulin resistance in the body.
Metformin reduces hepatic glucose production and enhances glucose uptake in peripheral tissues.
When used together, pioglitazone and metformin sustained release can provide better blood sugar control and help individuals with type 2 diabetes achieve target glucose levels. PIOSTERIS M 500  combination therapy is typically prescribed when diet and exercise alone are not sufficient to manage blood sugar levels effectively.
steris deals in Generic medicine refers to a medication that contains the same active ingredient(s), dosage form, strength, route of administration, and intended use as a brand-name drug. However, it is typically sold under its chemical or active ingredient name, rather than a specific brand name.
Here are some key points about generic medicines:
Active Ingredient: Generic medicines have the same active ingredient(s) as their brand-name counterparts. The active ingredient is the specific chemical component responsible for the therapeutic effect of the medication.
Bioequivalence: Generic medicines must demonstrate bioequivalence to the brand-name drug. This means that they must have similar pharmacokinetic properties, such as the rate and extent of absorption, in the body. Regulatory authorities set specific criteria for bioequivalence to ensure that generic medicines perform similarly to the brand-name drugs.
Cost Savings: Generic medicines are often more affordable than brand-name drugs. This is because generic manufacturers do not have to invest in extensive research and development or marketing costs associated with introducing a new drug to the market. Consequently, generic medicines offer cost savings to patients and healthcare systems.
For further information please contact:
info@sterispharma.com
Order Now -  https://www.sterisonline.com/product/piosteris-m-500-134243